搜索临床试验以:Phase 2b Dose-Ranging Study
总计126975个结果
-
University of OxfordEuropean and Developing Countries Clinical Trials Partnership (EDCTP)完全的
-
Acorda Therapeutics完全的
-
PhaseBio Pharmaceuticals Inc.完全的
-
Merck KGaA, Darmstadt, Germany完全的
-
Bristol-Myers Squibb完全的
-
Laboratorio Pablo Cassará S.R.L.National Council of Scientific and Technical Research, Argentina; Fundacion Sales; National Agency... 和其他合作者未知
-
Jennerex Biotherapeutics完全的
-
Merck Sharp & Dohme LLC完全的
-
BBB-Therapeutics B.V.完全的
-
Australasian Leukaemia and Lymphoma GroupMerck Sharp & Dohme LLC; Novartis Pharmaceuticals未知
-
Mitsubishi Tanabe Pharma CorporationVertex Pharmaceuticals Incorporated完全的
-
HanAll BioPharma Co., Ltd.完全的
-
Hexacath, France未知
-
Mayo ClinicUnity Health Toronto; Augusta University; Schering-Plough终止
-
National Cancer Institute (NCI)完全的
-
Biolex Therapeutics, Inc.完全的
-
Biolex Therapeutics, Inc.完全的
-
Nevada Cancer InstituteNational Institutes of Health (NIH); Schering-Plough终止
-
Ochsner Health SystemNewLink Genetics Corporation未知
-
Pacgen Biopharmaceuticals CorporationQuintiles, Inc.完全的
-
M.D. Anderson Cancer CenterKura Oncology, Inc.尚未招聘
-
M.D. Anderson Cancer CenterRegeneron Pharmaceuticals尚未招聘
-
M.D. Anderson Cancer CenterRigel Pharmaceuticals,Inc.尚未招聘
-
M.D. Anderson Cancer CenterQurient Co., Ltd.尚未招聘
-
National Institute of Allergy and Infectious Diseases...KBio Inc尚未招聘
-
Australasian Gastro-Intestinal Trials GroupAstraZeneca; Wayne Elphinstone Research Fund尚未招聘
-
Nanexa ABProfil Institut für Stoffwechselforschung GmbH尚未招聘
-
Hospices Civils de Lyon尚未招聘
-
Dana-Farber Cancer InstituteJohns Hopkins University; Translational Breast Cancer Research Consortium尚未招聘乳腺癌 | HER2阳性乳腺癌 | IV 期乳腺癌 | 乳腺癌女性 | 乳腺癌转移 | 雌激素受体阳性乳腺癌美国